
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Tosk discovers and develops new drugs to block the adverse effects of drugs with dose-limiting side effects and to block the activity of cancer genes. Tosks most advanced drug, TK-90, has successfully completed Phase 2 studies in head and neck cancer patients receiving high doses of chemotherapy. Tosk has two other drugs in development for cancer therapy side effect prevention and one to block KRAS gene activity which drives as many as 30% of all cancers
Oncology,pulmonary fibrosis,and nash
Tosk, inc operates in the Pharmaceutical manufacturing industry.
Tosk, inc's revenue is 11m - 100m
Tosk, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.